Open AccessUntoward effects of phenylbutazone (butazolidin)–A re‐evaluation
Author(s) -
Sperling Irving L.
Publication year - 1959
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/1529-0131(195906)2:3<203::aid-art1780020303>3.0.co;2-v
Subject(s) - phenylbutazone , medicine , dose , drug , clinical practice , intensive care medicine , pharmacology , physical therapy
This report of cumulative experiences with the administration of phenylbutazone to 590 patients for a variety of rheumatic diseases provides information of practical importance to those concerned with the use of this drug in clinical practice. Untoward effects were reduced significantly by lower dosages. Specific precautions are suggested.